1121 related articles for article (PubMed ID: 24071464)
1. Nucleoside triphosphates inhibit ADP, collagen, and epinephrine-induced platelet aggregation: role of P2Y₁ and P2Y₁₂ receptors.
Aslam M; Sedding D; Koshty A; Santoso S; Schulz R; Hamm C; Gündüz D
Thromb Res; 2013 Nov; 132(5):548-57. PubMed ID: 24071464
[TBL] [Abstract][Full Text] [Related]
2. Uridine Triphosphate Thio Analogues Inhibit Platelet P2Y
Gündüz D; Tanislav C; Sedding D; Parahuleva M; Santoso S; Troidl C; Hamm CW; Aslam M
Int J Mol Sci; 2017 Jan; 18(2):. PubMed ID: 28146050
[TBL] [Abstract][Full Text] [Related]
3. (N)-methanocarba-2MeSADP (MRS2365) is a subtype-specific agonist that induces rapid desensitization of the P2Y1 receptor of human platelets.
Bourdon DM; Mahanty SK; Jacobson KA; Boyer JL; Harden TK
J Thromb Haemost; 2006 Apr; 4(4):861-8. PubMed ID: 16634757
[TBL] [Abstract][Full Text] [Related]
4. P2Y1-receptors in human platelets which are pharmacologically distinct from P2Y(ADP)-receptors.
Fagura MS; Dainty IA; McKay GD; Kirk IP; Humphries RG; Robertson MJ; Dougall IG; Leff P
Br J Pharmacol; 1998 May; 124(1):157-64. PubMed ID: 9630355
[TBL] [Abstract][Full Text] [Related]
5. Two subtypes of G protein-coupled nucleotide receptors, P2Y(1) and P2Y(2) are involved in calcium signalling in glioma C6 cells.
Sabala P; Czajkowski R; Przybyłek K; Kalita K; Kaczmarek L; Barańska J
Br J Pharmacol; 2001 Jan; 132(2):393-402. PubMed ID: 11159687
[TBL] [Abstract][Full Text] [Related]
6. Adenosine diphosphate (ADP)-induced thromboxane A(2) generation in human platelets requires coordinated signaling through integrin alpha(IIb)beta(3) and ADP receptors.
Jin J; Quinton TM; Zhang J; Rittenhouse SE; Kunapuli SP
Blood; 2002 Jan; 99(1):193-8. PubMed ID: 11756171
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of adenine nucleotide analogues on shape change and aggregation induced by adnosine 5-diphosphate (ADP) in human platelets.
Park HS; Hourani SM
Br J Pharmacol; 1999 Jul; 127(6):1359-66. PubMed ID: 10455285
[TBL] [Abstract][Full Text] [Related]
8. Effect of P2Y1 and P2Y12 genetic polymorphisms on the ADP-induced platelet aggregation in a Korean population.
Kim KA; Song WG; Lee HM; Joo HJ; Park JY
Thromb Res; 2013 Aug; 132(2):221-6. PubMed ID: 23849096
[TBL] [Abstract][Full Text] [Related]
9. Molecular basis for ADP-induced platelet activation. II. The P2Y1 receptor mediates ADP-induced intracellular calcium mobilization and shape change in platelets.
Jin J; Daniel JL; Kunapuli SP
J Biol Chem; 1998 Jan; 273(4):2030-4. PubMed ID: 9442040
[TBL] [Abstract][Full Text] [Related]
10. The platelet P2Y12 receptor contributes to granule secretion through Ephrin A4 receptor.
Tournoij E; Koekman CA; Du VX; Roest M; Ruijtenbeek R; Moll FL; Akkerman JW
Platelets; 2012; 23(8):617-25. PubMed ID: 22273509
[TBL] [Abstract][Full Text] [Related]
11. Potentiation of platelet aggregation by heparin in human whole blood is attenuated by P2Y12 and P2Y1 antagonists but not aspirin.
Storey RF; May JA; Heptinstall S
Thromb Res; 2005; 115(4):301-7. PubMed ID: 15668190
[TBL] [Abstract][Full Text] [Related]
12. ADP secretion and subsequent P2Y12 receptor signalling play a crucial role in thrombin-induced ERK2 activation in human platelets.
Fälker K; Lange D; Presek P
Thromb Haemost; 2004 Jul; 92(1):114-23. PubMed ID: 15213852
[TBL] [Abstract][Full Text] [Related]
13. Agonist concentration-dependent differential responsivity of a human platelet purinergic receptor: pharmacological and kinetic studies of aggregation, deaggregation and shape change responses mediated by the purinergic P2Y1 receptor in vitro.
Maayani S; Schwarz TE; Patel ND; Craddock-Royal BD; Tagliente TM
Platelets; 2003; 14(7-8):445-62. PubMed ID: 14713514
[TBL] [Abstract][Full Text] [Related]
14. On the mechanism of plasmin-induced platelet aggregation. Implications of the dual role of granule ADP.
Ishii-Watabe A; Uchida E; Mizuguchi H; Hayakawa T
Biochem Pharmacol; 2000 Jun; 59(11):1345-55. PubMed ID: 10751543
[TBL] [Abstract][Full Text] [Related]
15. Prostaglandin E1 potentiates the effects of P2Y12 blockade on ADP-mediated platelet aggregation in vitro: Insights using short thromboelastography.
Khanna V; Armstrong PC; Warner TD; Curzen N
Platelets; 2015; 26(7):689-92. PubMed ID: 25734957
[TBL] [Abstract][Full Text] [Related]
16. Induction of novel agonist selectivity for the ADP-activated P2Y1 receptor versus the ADP-activated P2Y12 and P2Y13 receptors by conformational constraint of an ADP analog.
Chhatriwala M; Ravi RG; Patel RI; Boyer JL; Jacobson KA; Harden TK
J Pharmacol Exp Ther; 2004 Dec; 311(3):1038-43. PubMed ID: 15345752
[TBL] [Abstract][Full Text] [Related]
17. Ca2+ influx through P2X1 receptors amplifies P2Y1 receptor-evoked Ca2+ signaling and ADP-evoked platelet aggregation.
Jones S; Evans RJ; Mahaut-Smith MP
Mol Pharmacol; 2014 Sep; 86(3):243-51. PubMed ID: 24923466
[TBL] [Abstract][Full Text] [Related]
18. Effects of purine and pyrimidine nucleotides on intracellular Ca2+ in human eosinophils: activation of purinergic P2Y receptors.
Mohanty JG; Raible DG; McDermott LJ; Pelleg A; Schulman ES
J Allergy Clin Immunol; 2001 May; 107(5):849-55. PubMed ID: 11344352
[TBL] [Abstract][Full Text] [Related]
19. Agonist action of adenosine triphosphates at the human P2Y1 receptor.
Palmer RK; Boyer JL; Schachter JB; Nicholas RA; Harden TK
Mol Pharmacol; 1998 Dec; 54(6):1118-23. PubMed ID: 9855642
[TBL] [Abstract][Full Text] [Related]
20. Thrombopoietin complements G(i)- but not G(q)-dependent pathways for integrin {alpha}(IIb){beta}(3) activation and platelet aggregation.
Campus F; Lova P; Bertoni A; Sinigaglia F; Balduini C; Torti M
J Biol Chem; 2005 Jul; 280(26):24386-95. PubMed ID: 15863506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
